Cargando…

Determinants of Increased Serum Calprotectin in Patients with Type 2 Diabetes Mellitus

Circulating calprotectin is a potential biomarker for endovascular inflammation in type 2 diabetes mellitus (T2DM). We investigated the determinants of calprotectin and its relationship with the presence of cardiovascular disease (CVD) in 362 T2DM patients included in the Diabetes and Lifestyle Coho...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oosterwijk, Milou M., Bakker, Stephan J.L., Nilsen, Tom, Navis, Gerjan, Laverman, Gozewijn D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662274/ https://www.ncbi.nlm.nih.gov/pubmed/33138021 http://dx.doi.org/10.3390/ijms21218075

Ejemplares similares

Personalized Nutrition in Patients with Type 2 Diabetes and Chronic Kidney Disease: The Two-Edged Sword of Dietary Protein Intake
por: Oosterwijk, Milou M., et al.
Publicado: (2022)

Clinical and Dietary Determinants of Muscle Mass in Patients with Type 2 Diabetes: Data from the Diabetes and Lifestyle Cohort Twente
por: Jalving, Annis C., et al.
Publicado: (2021)

High Dietary Intake of Vegetable Protein Is Associated With Lower Prevalence of Renal Function Impairment: Results of the Dutch DIALECT-1 Cohort
por: Oosterwijk, Milou M., et al.
Publicado: (2019)

Low Physical Activity in Patients with Complicated Type 2 Diabetes Mellitus Is Associated with Low Muscle Mass and Low Protein Intake
por: Hagedoorn, Ilse J. M., et al.
Publicado: (2020)

Improvement of Sodium Status to Optimize the Efficacy of Renin-Angiotensin System Blockade
por: Laverman, Gozewijn D., et al.
Publicado: (2011)

Higher Dietary Magnesium Intake and Higher Magnesium Status Are Associated with Lower Prevalence of Coronary Heart Disease in Patients with Type 2 Diabetes
por: Gant, Christina M., et al.
Publicado: (2018)

Adherence to Statin Therapy and Attainment of LDL Cholesterol Targets in an Outpatient Population of Type 2 Diabetes Patients: Analysis in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
por: Beernink, Jelle M., et al.
Publicado: (2022)

Glucose Regulation Beyond HbA(1c) in Type 2 Diabetes Treated With Insulin: Real-World Evidence From the DIALECT-2 Cohort
por: den Braber, Niala, et al.
Publicado: (2021)

Lower Renal Function Is Associated With Derangement of 11-β Hydroxysteroid Dehydrogenase in Type 2 Diabetes
por: Gant, Christina Maria, et al.
Publicado: (2018)

Integrated Assessment of Pharmacological and Nutritional Cardiovascular Risk Management: Blood Pressure Control in the DIAbetes and LifEstyle Cohort Twente (DIALECT)
por: Gant, Christina M., et al.
Publicado: (2017)

Real-life achievement of lipid-lowering treatment targets in the DIAbetes and LifEstyle Cohort Twente: systemic assessment of pharmacological and nutritional factors
por: Gant, Christina M., et al.
Publicado: (2018)

Glycaemic control in the diabetes and Lifestyle Cohort Twente: A cross‐sectional assessment of lifestyle and pharmacological management on Hba1c target achievement
por: Jalving, Annis C., et al.
Publicado: (2018)

Body weight course in the DIAbetes and LifEstyle Cohort Twente (DIALECT-1)—A 20-year observational study
por: Gant, Christina M., et al.
Publicado: (2019)

Impact of Moderate Sodium Restriction and Hydrochlorothiazide on Iodine Excretion in Diabetic Kidney Disease: Data from a Randomized Cross-Over Trial
por: Binnenmars, S. Heleen, et al.
Publicado: (2019)

Lifestyle-Related Exposure to Cadmium and Lead is Associated with Diabetic Kidney Disease
por: Hagedoorn, Ilse J. M., et al.
Publicado: (2020)

Association of serum calprotectin with peripheral neuropathy in patients with type 2 diabetes mellitus
por: Velayutham, Ramanathan, et al.
Publicado: (2021)

Fibroblast Growth Factor 23 and Adverse Clinical Outcomes in Type 2 Diabetes: a Bitter-Sweet Symphony
por: Yeung, Stanley M. H., et al.
Publicado: (2020)

Liver Enzymes and the Development of Posttransplantation Diabetes Mellitus in Renal Transplant Recipients
por: Klaassen, Gerald, et al.
Publicado: (2017)

Requirements of an Application to Monitor Diet, Physical Activity and Glucose Values in Patients with Type 2 Diabetes: The Diameter
por: den Braber, Niala, et al.
Publicado: (2019)

Use of maximal dosage renin-angiotensin-aldosterone system inhibitors in a real life population of complicated type 2 diabetes – contraindications and opportunities
por: Gant, C. M., et al.
Publicado: (2023)

Indomethacin Reduces Glomerular and Tubular Damage Markers but Not Renal Inflammation in Chronic Kidney Disease Patients: A Post-Hoc Analysis
por: de Borst, Martin H., et al.
Publicado: (2012)

A new turbidimetric immunoassay for serum calprotectin for fully automatized clinical analysers
por: Nilsen, Tom, et al.
Publicado: (2015)

Effects of Education and Income on Incident Type 2 Diabetes and Cardiovascular Diseases: a Dutch Prospective Study
por: Duan, Ming-Jie F., et al.
Publicado: (2022)

Serum Proenkephalin A Levels and Mortality After Long-Term Follow-Up in Patients with Type 2 Diabetes Mellitus (ZODIAC-32)
por: van Hateren, Kornelis J. J., et al.
Publicado: (2015)

Creatinine Excretion Rate and Mortality in Type 2 Diabetes and Nephropathy
por: Sinkeler, Steef J., et al.
Publicado: (2013)

Renoprotective RAAS inhibition does not affect the association between worse renal function and higher plasma aldosterone levels
por: Gant, Christina M., et al.
Publicado: (2017)

Vitamin K Intake and Plasma Desphospho-Uncarboxylated Matrix Gla-Protein Levels in Kidney Transplant Recipients
por: Boxma, Paul Y., et al.
Publicado: (2012)

Mahalanobis distance, a novel statistical proxy of homeostasis loss is longitudinally associated with risk of type 2 diabetes
por: Flores-Guerrero, Jose L., et al.
Publicado: (2021)

Moderate dietary sodium restriction added to angiotensin converting enzyme inhibition compared with dual blockade in lowering proteinuria and blood pressure: randomised controlled trial
por: Slagman, Maartje C J, et al.
Publicado: (2011)

Physical Activity and the Development of Post-Transplant Diabetes Mellitus, and Cardiovascular- and All-Cause Mortality in Renal Transplant Recipients
por: Byambasukh, Oyuntugs, et al.
Publicado: (2020)

Pancreatic β-Cell Dysfunction and Risk of New-Onset Diabetes After Kidney Transplantation
por: Zelle, Dorien M., et al.
Publicado: (2013)

Fecal Calprotectin Is Increased in Stroke
por: Park, Shin Young, et al.
Publicado: (2021)

Serum calprotectin: A marker for early diagnosis of diabetic peripheral neuropathy
por: Balasundaram, Mahesh Kumar, et al.
Publicado: (2021)

Circulating Trimethylamine N-Oxide Is Associated with Increased Risk of Cardiovascular Mortality in Type-2 Diabetes: Results from a Dutch Diabetes Cohort (ZODIAC-59)
por: Flores-Guerrero, Jose L., et al.
Publicado: (2021)

Efficacy of metformin versus sulfonylurea derivative in HNF4A-MODY
por: Oosterom, Nicole, et al.
Publicado: (2022)

Plasma calprotectin and its association with cardiovascular disease manifestations, obesity and the metabolic syndrome in type 2 diabetes mellitus patients
por: Pedersen, Lise, et al.
Publicado: (2014)

Increased Resistin Serum Concentrations in Patients with Type 1 Diabetes Mellitus
por: Geyikli, İclal, et al.
Publicado: (2013)

Plasma Calprotectin Levels Associate with Suspected Metabolic-Associated Fatty Liver Disease and All-Cause Mortality in the General Population
por: Bourgonje, Arno R., et al.
Publicado: (2022)

The Midregional Fragment of Pro-A–Type Natriuretic Peptide, Blood Pressure, and Mortality in a Prospective Cohort Study of Patients With Type 2 Diabetes (ZODIAC-25)
por: van Hateren, Kornelis J.J., et al.
Publicado: (2013)

Extraction, isolation, and concentration of calprotectin antigen (S100A8/S100A9) from granulocytes
por: Nilsen, Tom, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_lenlmtm6ifriq5r031b1eqvd80